long intergenic non-protein coding RNA 2045Genealiases: []
Q-omics provides the consensus-scored LINC02045 profile across patient tissues and cancer cell-line models. LINC02045 expression is associated with patient survival in 7 of 34 cancer types, with the highest sampling consensus in BRCA. Among the 18 cancer types available for tumor–normal comparison, LINC02045 is differentially expressed in 1, with the highest sampling consensus in HNSC. Additionally, LINC02045 RNA expression shows 6,254 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight BRCA, HNSC, and STAD as cancer lineages where LINC02045 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02045 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02045 survival associations across molecular data types. LINC02045 RNA expression shows survival associations in the most cancer types (7). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02045 RNA expression–survival associations across cancer types. High LINC02045 expression shows unfavorable associations in BRCA, UCS, LGG, COAD and GBM, but favorable associations in TGCT. The BRCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .006). Together, the overview and detailed table identify BRCA as the clearest survival context for LINC02045 RNA expression.
This table summarizes LINC02045 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02045. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02045 shows higher tumor expression in HNSC. The HNSC box plot shows higher LINC02045 RNA expression in tumor versus normal tissue (log2 FC = +0.025, t-test p = .044).
This table shows molecular features associated with LINC02045 in patient tissues and cancer cell lines. In patient samples, LINC02045 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.
